Antidepressant Effects on cAMP Specific Phosphodiesterase (PDE4) in Depressed Patients
|ClinicalTrials.gov Identifier: NCT00369798|
Recruitment Status : Completed
First Posted : August 29, 2006
Last Update Posted : October 6, 2017
National Institute of Mental Health (NIMH)
Information provided by (Responsible Party):
National Institutes of Health Clinical Center (CC) ( National Institute of Mental Health (NIMH) )
No Study Results Posted on ClinicalTrials.gov for this Study
|Recruitment Status :||Completed|
|Primary Completion Date :||June 16, 2016|
|Study Completion Date :||October 12, 2016|
Andersen PH, Klysner R, Geisler A. Cyclic AMP phosphodiesterase activity in rat brain following chronic treatment with lithium, imipramine, reserpine, and combinations of lithium with imipramine or reserpine. Acta Pharmacol Toxicol (Copenh). 1983 Oct;53(4):337-43.
Blier P, de Montigny C. Current advances and trends in the treatment of depression. Trends Pharmacol Sci. 1994 Jul;15(7):220-6. Review.